The effect of Paxirasol nasal spray (EGIS) has been examined in 25 patients following open heart surgery. In 18 of the patients increased secretion, in 7 crusting due to dryness of mucosa were observed as accompanying symptoms. These symptoms ceased in response to Paxirasol therapy, in the former cases within one week, in the latter ones within two weeks. The drug was applied in daily 3-5 times 1-mg (3-5 x 5 puffs) doses.

Download full-text PDF

Source

Publication Analysis

Top Keywords

paxirasol nasal
8
nasal spray
8
open heart
8
observations paxirasol
4
spray therapy
4
therapy open
4
heart operations
4
operations paxirasol
4
spray egis
4
egis examined
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!